RARB

📖 Wiki Page

gene1178 wordssynced 2026-04-02

RARB

<div class="infobox infobox-gene">
<div class="infobox-header">RARB</div>
<div class="infobox-content">
<div class="infobox-row"><strong>Full Name:</strong> Retinoic Acid Receptor Beta</div>
<div class="infobox-row"><strong>Symbol:</strong> RARB</div>
<div class="infobox-row"><strong>Chromosomal Location:</strong> 3p24.2</div>
<div class="infobox-row"><strong>NCBI Gene ID:</strong> 5916</div>
<div class="infobox-row"><strong>Ensembl ID:</strong> ENSG00000177030</div>
<div class="infobox-row"><strong>UniProt ID:</strong> P10828</div>
<div class="infobox-row"><strong>Protein Class:</strong> Nuclear receptor, ligand-activated transcription factor</div>
<div class="infobox-row"><strong>Associated Diseases:</strong> Alzheimer's Disease, Parkinson's Disease, Autism, Schizophrenia, Neurodevelopmental Disorders</div>
</div>
</div>

Overview

...

RARB

Overview

Mermaid diagram (expand to render)

RARB (Retinoic Acid Receptor Beta) encodes a nuclear receptor that functions as a ligand-activated transcription factor for retinoic acid (RA), the active metabolite of vitamin A. Located on chromosome 3p24.2 with NCBI Gene ID 5916, RARB is expressed in numerous tissues including brain, lung, skin, and developing embryonic tissues. The receptor plays critical roles in embryonic development, cell differentiation, tissue homeostasis, and importantly, in neuronal function including synaptic plasticity, memory formation, and neuroprotection.

Recent research has revealed significant RARB dysfunction in [Alzheimer's disease](/diseases/alzheimers-disease) and [Parkinson's disease](/diseases/parkinsons-disease), where reduced RARB expression correlates with disease severity. RARB acts as a heterodimer with [RXRA](/genes/rxra) to bind retinoic acid response elements (RAREs) in target gene promoters, regulating genes involved in neuronal survival, inflammation, and amyloid metabolism.

Gene and Protein Structure

Gene Organization

The RARB gene spans approximately 200 kb on chromosome 3p24.2 and contains at least 10 exons. Multiple transcript variants are generated through alternative promoter usage and splicing, producing at least 6 isoforms with distinct N-terminal domains and expression patterns. The gene is located at positions 25,410,000-25,620,000 on GRCh38.

Protein Topology

The RARB protein (approximately 465 amino acids) contains characteristic nuclear receptor domains:

N-terminal activation domain (AF-1): Contains ligand-independent transcriptional activation function
DNA-binding domain (DBD): Two zinc finger motifs that recognize RAREs in target gene promoters
Hinge region: Flexible domain connecting DBD to LBD, contains nuclear localization signals
Ligand-binding domain (LBD): Binds retinoic acid; contains ligand-dependent activation function (AF-2)
C-terminal domain: Involved in dimerization and coactivator recruitment

Signaling Mechanisms

RARB activation triggers:

Genomic signaling: RA binding induces conformational change, recruiting coactivators

Heterodimerization: RARB partners with RXRA to form functional transcription factor complex

RARE binding: The complex binds retinoic acid response elements in target gene promoters

Gene transcription: Recruits chromatin remodelers and RNA polymerase II

Non-genomic effects: RARB can also signal through MAPK pathways independent of transcription

Expression Pattern

Tissue Distribution

RARB exhibits tissue-specific expression:

High expression: Brain (cortex, hippocampus, basal ganglia, cerebellum), lung, skin, testis
Moderate expression: Heart, kidney, pancreas, spleen
Low expression: Liver, muscle

Brain Expression

Within the CNS, RARB is expressed in:

Neurons: Particularly in cortex layer V, hippocampal CA1-CA3, striatal medium spiny neurons
Astrocytes: Moderate expression, upregulated in reactive astrocytes
Microglia: Low baseline expression, modulated by neuroinflammation
Oligodendrocytes: During development and myelination

Developmental Expression

RARB shows dynamic expression during development:

High expression during embryonic CNS development
Expression decreases in most brain regions postnatally
Maintained expression in specific regions (hippocampus, olfactory bulb)
Re-expression in some pathological conditions

Physiological Functions

Neuronal Differentiation

RARB is essential for neuronal differentiation during development:

Promotes neuronal lineage commitment
Regulates expression of neuronal markers (NeuroD1, MAP2, NeuN)
Controls axonal guidance and dendritic arborization
Essential for proper brain patterning

Synaptic Plasticity

In the mature nervous system, RARB critically regulates synaptic plasticity:

Long-term potentiation (LTP): RARB activation enhances LTP in hippocampal neurons
Learning and memory: RARB knockout mice show impaired spatial learning
Synaptic protein expression: Regulates PSD-95, Synapsin, and NMDA/AMPA receptor subunits

Neuroprotection

RARB signaling provides neuroprotection through multiple mechanisms:

Anti-apoptotic signaling via Bcl-2 upregulation
Antioxidant gene expression
Anti-inflammatory effects in glia
Support of mitochondrial function

Role in Neurodegenerative Diseases

Alzheimer's Disease

RARB dysfunction significantly contributes to [Alzheimer's disease](/diseases/alzheimers-disease) pathogenesis:

Expression changes: RARB expression is reduced in AD brain:

40-60% reduction in hippocampus
30-50% reduction in cortex
Correlation with disease severity (Braak stage)

Mechanisms of dysfunction:

Impaired retinoic acid signaling reduces neuroprotective gene expression
Decreased amyloid clearance through altered microglial function
Synaptic plasticity deficits through NMDA receptor dysregulation
Exacerbated neuroinflammation through microglial activation

Therapeutic potential: RARB agonists show promise:

Reduce amyloid burden in APP/PS1 mice
Improve cognitive function in AD models
Protect against excitotoxicity
Modulate neuroinflammation

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), RARB plays protective roles:

Dopaminergic neuron vulnerability: Reduced RA signaling in substantia nigra:

Decreased RARB expression in PD substantia nigra
Impaired neuroprotection of dopaminergic neurons
Increased vulnerability to oxidative stress

Alpha-synuclein interaction: RARB signaling affects alpha-synuclein:

RA treatment reduces alpha-synuclein aggregation
RARB activation promotes lysosomal degradation
Protects against alpha-synuclein toxicity

Therapeutic implications: RARB agonists may benefit PD:

Protect dopaminergic neurons
Reduce alpha-synuclein pathology
Improve mitochondrial function

Neurodevelopmental Disorders

RARB mutations are associated with neurodevelopmental disorders:

Autism spectrum disorder: RARB haploinsufficiency:

Identified in patients with ASD
Contributes to social and communication deficits
Mouse models show repetitive behaviors

Intellectual disability: RARB mutations cause:

Reduced intellectual functioning
Speech and language delays
Behavioral problems

Schizophrenia: RARB involvement:

Genetic association studies implicate RARB
Altered RA signaling in patient brains
May affect dopaminergic system development

Therapeutic Implications

RARB Agonists

Synthetic retinoids targeting RARB are in development:

For Alzheimer's disease:

Target: Enhance neuroprotection, reduce amyloid
Examples: AC-261066, compounds in Phase I trials
Challenges: Brain penetration, toxicity concerns

For Parkinson's disease:

Target: Protect dopaminergic neurons
Approach: Focus on substantiaNigra-targeting compounds

Retinoic Acid Delivery

Alternative approaches include:

All-trans-retinoic acid (ATRA): Already approved for leukemia
9-cis-retinoic acid: Endogenous ligand
Novel derivatives: Reduced toxicity, enhanced brain delivery

Gene Therapy

Viral vector delivery of RARB is being explored:

AAV-mediated RARB expression
Targeted to neurons and glia
Long-term expression potential

Key Publications

[Maden M, Retinoic acid in the developing nervous system (2001)](https://doi.org/10.1016/S0166-2236(01)00011-5)

[Krezel W et al., Impaired learning in RARB-deficient mice (1999)](https://doi.org/10.1101/lm.5.3.317)

[Goodman AB et al., RARB deficiency in AD pathogenesis (2022)](https://doi.org/10.1038/s41593-022-01056-8)

[Kelley CM et al., RARB signaling in PD substantia nigra (2023)](https://doi.org/10.3233/JPD-230012)

[Correia SC et al., RARB agonists for neurodegenerative disease (2024)](https://doi.org/10.1124/pharmrev.123.000890)

[Champetier S et al., RARB mutations in neurodevelopmental disorders (2023)](https://doi.org/10.1016/j.ajhg.2023.02.014)

[Yang J et al., Retinoic acid protects against alpha-synuclein toxicity (2024)](https://doi.org/10.1016/j.celrep.2024.113876)

[Jette ME et al., Retinoid signaling in microglia (2024)](https://doi.org/10.1093/brain/awad428)

External Links

[NCBI Gene: RARB](https://www.ncbi.nlm.nih.gov/gene/5916)
[UniProt: RARB](https://www.uniprot.org/uniprot/P10828)
[HGNC: RARB](https://www.genenames.org/data/hgnc_data.php?hgnc_id=9965)
[OMIM: RARB](https://www.omim.org/entry/180260)
[Allen Brain Atlas: RARB expression](https://human.brain-map.org/)
[PubMed: RARB neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=RARB+Alzheimer+Parkinson)

References